Surgical Management of Advanced Glottic Cancer
Copyright © 2022 Elsevier Inc. All rights reserved..
In advanced glottic cancer, it is widely known that definitive chemoradiation can result in comparable survival outcomes to primary surgery. This deserves consideration given the immense effects total laryngectomy (TL) has on patients. It is important to consider that not all advanced glottic tumors should be treated in the same way, and surgical management remains a critical consideration for optimization of local control and survival outcomes. Advances in organ preservation surgery and the more developed understanding of the survival benefits of TL in extensive T4 disease further support the importance of surgery in the management of advanced glottic cancer.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:56 |
|---|---|
| Enthalten in: |
Otolaryngologic clinics of North America - 56(2023), 2 vom: 08. Apr., Seite 275-283 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Poonia, Seerat K [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Advanced glottic cancer |
|---|
| Anmerkungen: |
Date Completed 11.04.2023 Date Revised 11.04.2023 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.otc.2022.12.007 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM355355884 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM355355884 | ||
| 003 | DE-627 | ||
| 005 | 20231226064155.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.otc.2022.12.007 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1184.xml |
| 035 | |a (DE-627)NLM355355884 | ||
| 035 | |a (NLM)37030940 | ||
| 035 | |a (PII)S0030-6665(22)00189-X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Poonia, Seerat K |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Surgical Management of Advanced Glottic Cancer |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 11.04.2023 | ||
| 500 | |a Date Revised 11.04.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2022 Elsevier Inc. All rights reserved. | ||
| 520 | |a In advanced glottic cancer, it is widely known that definitive chemoradiation can result in comparable survival outcomes to primary surgery. This deserves consideration given the immense effects total laryngectomy (TL) has on patients. It is important to consider that not all advanced glottic tumors should be treated in the same way, and surgical management remains a critical consideration for optimization of local control and survival outcomes. Advances in organ preservation surgery and the more developed understanding of the survival benefits of TL in extensive T4 disease further support the importance of surgery in the management of advanced glottic cancer | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Advanced glottic cancer | |
| 650 | 4 | |a Laryngectomy | |
| 650 | 4 | |a Organ preservation | |
| 650 | 4 | |a Primary chemoradiation | |
| 700 | 1 | |a Nicolli, Elizabeth |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Otolaryngologic clinics of North America |d 1970 |g 56(2023), 2 vom: 08. Apr., Seite 275-283 |w (DE-627)NLM000170666 |x 0030-6665 |7 nnns |
| 773 | 1 | 8 | |g volume:56 |g year:2023 |g number:2 |g day:08 |g month:04 |g pages:275-283 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.otc.2022.12.007 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 56 |j 2023 |e 2 |b 08 |c 04 |h 275-283 | ||